Several clinical studies have reported that PD-L1 overexpression is related to a poor prognosis for several types of tumors, including renal-cell carcinoma, bladder cancer, esophageal cancer, pancreatic cancer, gastric cancer, hepatocellular carcinoma, and ovarian cancer [41, 47–53]. The gene discussed is CD274; the disease is ovarian carcinoma.